However, VDAC1 is overexpressed (upregulated) in cervical carcinoma (Hela cell line) [28], adrenocortical carcinoma (Human SW13 and H295R) [17], myeloma [18], lung cancer [19], non-small cell lung carcinoma [20], human gastric carcinoma [21], and ovarian and endometrial carcinoma (OV-TRL12B, EN-TRL 67 T cell line) [22]. Here, VDAC1 is linked to plasma cell myeloma.